These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11815234)

  • 41. Academic-industrial partnerships in drug discovery in the age of genomics.
    Harris T; Papadopoulos S; Goldstein DB
    Trends Biotechnol; 2015 Jun; 33(6):320-2. PubMed ID: 25987446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel detection strategies for drug discovery.
    Hemmilä IA; Hurskainen P
    Drug Discov Today; 2002 Sep; 7(18 Suppl):S150-6. PubMed ID: 12546882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug target identification: a question of biology.
    Smith C
    Nature; 2004 Mar; 428(6979):225-31. PubMed ID: 15014514
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug Discovery and Development Asia-Pacific Conference 2005. Strategies and case studies of successful alliances, licensing and outsourcing partnerships.
    Alger L
    IDrugs; 2005 Aug; 8(8):639-41. PubMed ID: 16044371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maximizing the value of genomics in the drug discovery and development process.
    Spence P
    Prog Drug Res; 2003; 60():159-70. PubMed ID: 12790342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HTS in the new millennium: the role of pharmacology and flexibility.
    Landro JA; Taylor IC; Stirtan WG; Osterman DG; Kristie J; Hunnicutt EJ; Rae PM; Sweetnam PM
    J Pharmacol Toxicol Methods; 2000; 44(1):273-89. PubMed ID: 11274895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic information, genomic technologies, and the future of drug discovery.
    Bumol TF; Watanabe AM
    JAMA; 2001 Feb; 285(5):551-5. PubMed ID: 11176857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive essential gene identification as a platform for novel anti-infective drug discovery.
    Haselbeck R; Wall D; Jiang B; Ketela T; Zyskind J; Bussey H; Foulkes JG; Roemer T
    Curr Pharm Des; 2002; 8(13):1155-72. PubMed ID: 12052225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rising star: pharmacological development in China.
    Schaffhausen J
    Trends Pharmacol Sci; 2013 Oct; 34(10):531. PubMed ID: 24054046
    [No Abstract]   [Full Text] [Related]  

  • 50. Positioning ADMET in silico tools in drug discovery.
    Modi S
    Drug Discov Today; 2004 Jan; 9(1):14-5. PubMed ID: 14765543
    [No Abstract]   [Full Text] [Related]  

  • 51. Nanotechnologies and health.
    Lubner GC
    Boll Chim Farm; 2003 Apr; 142(3):98. PubMed ID: 12806824
    [No Abstract]   [Full Text] [Related]  

  • 52. Natural product discovery: past, present, and future.
    Katz L; Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):155-76. PubMed ID: 26739136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New advances in drug discovery.
    Macphee C
    Expert Opin Investig Drugs; 2004 Sep; 13(9):1213-5. PubMed ID: 15330753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Will genes become an engine to the industry?].
    Nylund S; Sibakov M
    Duodecim; 2000; 116(16):1763-8. PubMed ID: 12001455
    [No Abstract]   [Full Text] [Related]  

  • 55. What does it take to produce a breakthrough drug?
    Calcoen D; Elias L; Yu X
    Nat Rev Drug Discov; 2015 Mar; 14(3):161-2. PubMed ID: 25722234
    [No Abstract]   [Full Text] [Related]  

  • 56. Defining innovation.
    Hughes B
    Nat Rev Drug Discov; 2009 Sep; 8(9):683-4. PubMed ID: 19721435
    [No Abstract]   [Full Text] [Related]  

  • 57. Application of chemical biology in target identification and drug discovery.
    Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
    Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Avoiding premature licensing.
    Kessel M; Hall S
    Nat Rev Drug Discov; 2006 Dec; 5(12):985-6. PubMed ID: 17201025
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pharmacology and pharmacotherapy in Japan].
    Van Zwieten PA
    Ned Tijdschr Geneeskd; 1990 Mar; 134(11):549-50. PubMed ID: 2320149
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of antisense oligonucleotides in functional genomics and target validation.
    Ravichandran LV; Dean NM; Marcusson EG
    Oligonucleotides; 2004; 14(1):49-64. PubMed ID: 15104896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.